Completed
Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients
NCT03359850
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Newport Beach, California, United States
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site Atlanta, Georgia, United States